The raw feed
Latest filings
Every transaction from every Form 4, as filed, newest first. Open-market buys (P) and sells (S) become signals; the rest is shown for completeness.
| Date | Company | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2022 | ARTNA ARTESIAN RESOURCES CORP | Dian C Taylor C.E.O. President | XIn-the-money exercise Class A Non-voting Common Stock | +1,019 | $21.86 | $22k | 106,040 | Dec 15, 2022 |
| Dec 14, 2022 | ARTNA ARTESIAN RESOURCES CORP | Dian C Taylor C.E.O. President | XIn-the-money exercise Non-qualified Stock Option (Right to Buy)derivative | -1,019 | $0.00 | $0 | 0 | Dec 15, 2022 |
| Dec 13, 2022 | ARTNA ARTESIAN RESOURCES CORP | Dian C Taylor C.E.O. President | XIn-the-money exercise Class A Non-voting Common Stock | +853 | $21.86 | $19k | 105,874 | Dec 14, 2022 |
| Dec 13, 2022 | ARTNA ARTESIAN RESOURCES CORP | Dian C Taylor C.E.O. President | XIn-the-money exercise Non-qualified Stock Option (Right to Buy)derivative | -853 | $0.00 | $0 | 1,019 | Dec 14, 2022 |
| Dec 12, 2022 | ARTNA ARTESIAN RESOURCES CORP | Dian C Taylor C.E.O. President | XIn-the-money exercise Class A Non-voting Common Stock | +110 | $21.86 | $2,405 | 105,131 | Dec 13, 2022 |
| Dec 12, 2022 | ARTNA ARTESIAN RESOURCES CORP | Dian C Taylor C.E.O. President | XIn-the-money exercise Non-qualified Stock Option (Right to Buy)derivative | -110 | $0.00 | $0 | 1,872 | Dec 13, 2022 |
| Dec 9, 2022 | ARTNA ARTESIAN RESOURCES CORP | Dian C Taylor C.E.O. President | XIn-the-money exercise Class A Non-voting Common Stock | +4,768 | $21.86 | $104k | 109,789 | Dec 13, 2022 |
| Dec 9, 2022 | ARTNA ARTESIAN RESOURCES CORP | Dian C Taylor C.E.O. President | XIn-the-money exercise Non-qualified Stock Option (Right to Buy)derivative | -4,768 | $0.00 | $0 | 1,982 | Dec 13, 2022 |
| Dec 9, 2022 | DLTR DOLLAR TREE, INC. | Paul C Hilal director | XIn-the-money exercise Call options on cash-settled forwards (right to buy)derivativeindirect: See footnotes | -114,749 | - | - | 0 | Dec 13, 2022 |
| Dec 9, 2022 | DLTR DOLLAR TREE, INC. | Paul C Hilal director | XIn-the-money exercise Cash-settled forward contractsderivativeindirect: See footnotes | +114,749 | - | - | 114,749 | Dec 13, 2022 |
| Dec 9, 2022 | DLTR DOLLAR TREE, INC. | Paul C Hilal director | XIn-the-money exercise Call options on cash-settled forwards (right to buy)derivativeindirect: See footnotes | -35,171 | - | - | 0 | Dec 13, 2022 |
| Dec 9, 2022 | DLTR DOLLAR TREE, INC. | Paul C Hilal director | XIn-the-money exercise Cash-settled forward contractsderivativeindirect: See footnotes | +35,171 | - | - | 35,171 | Dec 13, 2022 |
| Dec 9, 2022 | DLTR DOLLAR TREE, INC. | Paul C Hilal director | XIn-the-money exercise Call options on cash-settled forwards (right to buy)derivativeindirect: See footnotes | -240,105 | - | - | 0 | Dec 13, 2022 |
| Dec 9, 2022 | DLTR DOLLAR TREE, INC. | Paul C Hilal director | XIn-the-money exercise Cash-settled forward contractsderivativeindirect: See footnotes | +240,105 | - | - | 240,105 | Dec 13, 2022 |
| Dec 9, 2022 | DLTR DOLLAR TREE, INC. | Paul C Hilal director | XIn-the-money exercise Call options on cash-settled forwards (right to buy)derivativeindirect: See footnotes | -290,000 | - | - | 0 | Dec 13, 2022 |
| Dec 9, 2022 | DLTR DOLLAR TREE, INC. | Paul C Hilal director | XIn-the-money exercise Cash-settled forward contractsderivativeindirect: See footnotes | +290,000 | - | - | 290,000 | Dec 13, 2022 |
| Dec 9, 2022 | DLTR DOLLAR TREE, INC. | Paul C Hilal director | XIn-the-money exercise Call options on cash-settled forwards (right to buy)derivativeindirect: See footnotes | -388,000 | - | - | 0 | Dec 13, 2022 |
| Dec 9, 2022 | DLTR DOLLAR TREE, INC. | Paul C Hilal director | XIn-the-money exercise Cash-settled forward contractsderivativeindirect: See footnotes | +388,000 | - | - | 388,000 | Dec 13, 2022 |
| Dec 9, 2022 | DLTR DOLLAR TREE, INC. | Paul C Hilal director | XIn-the-money exercise Call options on cash-settled forwards (right to buy)derivativeindirect: See footnotes | -310,000 | - | - | 0 | Dec 13, 2022 |
| Dec 9, 2022 | DLTR DOLLAR TREE, INC. | Paul C Hilal director | XIn-the-money exercise Cash-settled forward contractsderivativeindirect: See footnotes | +310,000 | - | - | 310,000 | Dec 13, 2022 |
| Dec 9, 2022 | DLTR DOLLAR TREE, INC. | Paul C Hilal director | XIn-the-money exercise Call options on cash-settled forwards (right to buy)derivativeindirect: See footnotes | -128,986 | - | - | 0 | Dec 13, 2022 |
| Dec 9, 2022 | DLTR DOLLAR TREE, INC. | Paul C Hilal director | XIn-the-money exercise Cash-settled forward contractsderivativeindirect: See footnotes | +128,986 | - | - | 128,986 | Dec 13, 2022 |
| Dec 8, 2022 | MXC MEXCO ENERGY CORP | Thomas H Decker director | XIn-the-money exercise STOCK OPTIONSderivative | +5,000 | $3.34 | $17k | 5,000 | Dec 12, 2022 |
| Dec 8, 2022 | MXC MEXCO ENERGY CORP | Thomas H Decker director | XIn-the-money exercise STOCK OPTIONSderivative | +5,000 | $3.34 | $17k | 5,000 | Dec 12, 2022 |
| Dec 7, 2022 | HRGN Harvard Apparatus Regenerative Technology, Inc. | DST Capital LLC owner | XIn-the-money exercise Common Stock | +7,000 | $2.00 | $14k | 3,665,277 | Dec 9, 2022 |
| Dec 7, 2022 | HRGN Harvard Apparatus Regenerative Technology, Inc. | DST Capital LLC owner | XIn-the-money exercise Warrants (right to buy)derivative | -7,000 | $0.00 | $0 | 0 | Dec 9, 2022 |
| Dec 7, 2022 | HRGN Harvard Apparatus Regenerative Technology, Inc. | Hong Yu PRESIDENT | XIn-the-money exercise Common Stockindirect: The spouse of the reporting person | +300,000 | $2.00 | $600k | 306,135 | Dec 9, 2022 |
| Dec 7, 2022 | HRGN Harvard Apparatus Regenerative Technology, Inc. | Hong Yu PRESIDENT | XIn-the-money exercise Warrants (right to buy)derivativeindirect: The spouse of the reporting person | -300,000 | $0.00 | $0 | 0 | Dec 9, 2022 |
| Dec 7, 2022 | HRGN Harvard Apparatus Regenerative Technology, Inc. | Jing Chen director | XIn-the-money exercise Common Stock | +174,000 | $2.00 | $348k | 210,000 | Dec 9, 2022 |
| Dec 7, 2022 | HRGN Harvard Apparatus Regenerative Technology, Inc. | Jing Chen director | XIn-the-money exercise Warrants (right to buy)derivative | -174,000 | $0.00 | $0 | 0 | Dec 9, 2022 |
| Dec 7, 2022 | LAZY Lazydays Holdings, Inc. | Coliseum Capital Management, LLC director, owner | XIn-the-money exercise Common Stockindirect: See footnotes | +496,894 | $11.50 | $5.7M | 3,602,004 | Dec 9, 2022 |
| Dec 7, 2022 | LAZY Lazydays Holdings, Inc. | Coliseum Capital Management, LLC director, owner | XIn-the-money exercise Warrantsderivativeindirect: See Footnote | -496,894 | $0.00 | $0 | 0 | Dec 9, 2022 |
| Dec 6, 2022 | TCON Tracon Pharmaceuticals, Inc. | Opaleye Management Inc. owner | XIn-the-money exercise Common Stock, par value $0.01 per shareindirect: By Opaleye, L.P. | +221,539 | $0.01 | $2,215 | 4,011,539 | Dec 8, 2022 |
| Dec 6, 2022 | TCON Tracon Pharmaceuticals, Inc. | Opaleye Management Inc. owner | XIn-the-money exercise Prefunded Warrantsderivativeindirect: By Opaleye, L.P. | -221,539 | $0.01 | $2,215 | 1,667,974 | Dec 8, 2022 |
| Dec 2, 2022 | LWLG Lightwave Logic, Inc. | Frederick J Leonberger director | XIn-the-money exercise Common Stock | +125,000 | $0.98 | $123k | 130,182 | Dec 6, 2022 |
| Dec 2, 2022 | LWLG Lightwave Logic, Inc. | Frederick J Leonberger director | XIn-the-money exercise Warrant (Right to Buy)derivative | -125,000 | $0.00 | $0 | 899,000 | Dec 6, 2022 |
| Dec 5, 2022 | BWB Bridgewater Bancshares Inc | Nicholas L. Place CHIEF LENDING OFFICER | XIn-the-money exercise option to buyderivative | -5,000 | $0.00 | $0 | 0 | Dec 6, 2022 |
| Dec 5, 2022 | BWB Bridgewater Bancshares Inc | Nicholas L. Place CHIEF LENDING OFFICER | XIn-the-money exercise option to buyderivative | -5,000 | $0.00 | $0 | 20,000 | Dec 6, 2022 |
| Dec 1, 2022 | MYO MYOMO, INC. | Thomas F Kirk director | XIn-the-money exercise Common Stock | +333 | $0.00 | $0 | 26,513 | Dec 5, 2022 |
| Dec 1, 2022 | MYO MYOMO, INC. | Thomas F Kirk director | XIn-the-money exercise Warrantsderivative | -333 | $0.00 | $0 | 0 | Dec 5, 2022 |
| Nov 30, 2022 | CAR AVIS BUDGET GROUP, INC. | SRS Investment Management, LLC director, owner | XIn-the-money exercise Common Stockindirect: See Footnote | +300,869 | $23.52 | $7.1M | 18,430,882 | Dec 2, 2022 |
| Nov 30, 2022 | CAR AVIS BUDGET GROUP, INC. | SRS Investment Management, LLC director, owner | XIn-the-money exercise Common Stockindirect: See Footnote | +385,672 | $23.52 | $9.1M | 18,430,882 | Dec 2, 2022 |
| Nov 30, 2022 | CAR AVIS BUDGET GROUP, INC. | SRS Investment Management, LLC director, owner | XIn-the-money exercise Common Stockindirect: See Footnote | +313,459 | $35.33 | $11M | 18,430,882 | Dec 2, 2022 |
| Nov 30, 2022 | CAR AVIS BUDGET GROUP, INC. | SRS Investment Management, LLC director, owner | XIn-the-money exercise Common Stockindirect: See Footnote | +500,000 | $48.75 | $24M | 18,430,882 | Dec 2, 2022 |
| Nov 30, 2022 | CAR AVIS BUDGET GROUP, INC. | SRS Investment Management, LLC director, owner | XIn-the-money exercise Equity Swap (obligation to buy)derivativeindirect: See Footnote | -1 | - | - | 0 | Dec 2, 2022 |
| Nov 30, 2022 | CAR AVIS BUDGET GROUP, INC. | SRS Investment Management, LLC director, owner | XIn-the-money exercise Equity Swap (obligation to buy)derivativeindirect: See Footnote | -1 | - | - | 234,891 | Dec 2, 2022 |
| Nov 30, 2022 | CAR AVIS BUDGET GROUP, INC. | SRS Investment Management, LLC director, owner | XIn-the-money exercise Equity Swap (obligation to buy)derivativeindirect: See Footnote | -1 | - | - | 0 | Dec 2, 2022 |
| Nov 30, 2022 | CAR AVIS BUDGET GROUP, INC. | SRS Investment Management, LLC director, owner | XIn-the-money exercise Equity Swap (obligation to buy)derivativeindirect: See Footnote | -1 | - | - | 0 | Dec 2, 2022 |
| Nov 30, 2022 | HLVX HilleVax, Inc. | Takeda Pharmaceutical Co Ltd owner | XIn-the-money exercise Common Stockindirect: See Explanation of Responses | +5,883,500 | $0.00 | $0 | 6,724,000 | Dec 1, 2022 |
| Nov 30, 2022 | HLVX HilleVax, Inc. | Takeda Pharmaceutical Co Ltd owner | XIn-the-money exercise Warrant (Right to Buy)derivativeindirect: See Explanation of Responses | -5,883,500 | $0.00 | $0 | 0 | Dec 1, 2022 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.